De-implementing low-value care in endocrinology

Naykky Singh Ospina, Ramzi G Salloum, Spyridoula Maraka, Juan P Brito, Naykky Singh Ospina, Ramzi G Salloum, Spyridoula Maraka, Juan P Brito

Abstract

Low-value care exposes patients to ineffective, costly, and potentially harmful care. In endocrinology, low-value care practices are common in the care of patients with highly prevalent conditions. There is an urgent need to move past the identification of these practices to an active process of de-implementation. However, clinicians, researchers, and other stakeholders might lack familiarity with the frameworks and processes that can help guide successful de-implementation. To address this gap and support the de-implementation of low-value care, we provide a summary of low-value care practices in endocrinology and a primer on the fundamentals of de-implementation science. Our goal is to increase awareness of low-value care within endocrinology and suggest a path forward for addressing low-value care using principles of de-implementation science.

Keywords: De-implementation; Endocrinology; Implementation science; Low-value care.

Conflict of interest statement

Conflicts of interest/Competing interests: None of the authors have any conflict of interest related to the manuscript.

Figures

Figure 1.
Figure 1.
Steps and factors that guide the de-implementation process.

References

    1. Dzau VJ, McClellan M, McGinnis JM, and Finkelman EMeditors.: Vital directions for health & health care: An initiative of the National Academy of Medicine. In.: National Academy of Medicine.; 2017.
    1. Sampson UKA, Chambers D, Riley W, Glass RI, Engelgau MM, Mensah GA: Implementation Research The Fourth Movement of the Unfinished Translation Research Symphony. Glob Heart 2016, 11(1):153–158.
    1. Brownlee S, Chalkidou K, Doust J, Elshaug AG, Glasziou P, Heath I, Nagpal S, Saini V, Srivastava D, Chalmers K et al.: Evidence for overuse of medical services around the world. Lancet 2017, 390(10090):156–168.
    1. Korenstein D, Chimonas S, Barrow B, Keyhani S, Troy A, Lipitz-Snyderman A: Development of a Conceptual Map of Negative Consequences for Patients of Overuse of Medical Tests and Treatments. JAMA Intern Med 2018, 178(10):1401–1407.
    1. Berwick DM, Hackbarth AD: Eliminating waste in US health care. JAMA 2012, 307(14):1513–1516.
    1. Norton WE, Chambers DA, Kramer BS: Conceptualizing de-implementation in cancer care delivery. J Clin Oncol 2019, 37(2):93–96.
    1. Norton WE, Kennedy AE, Chambers DA: Studying de-implementation in health: An analysis of funded research grants. Implement Sci 2017, 12(1).
    1. National Institue of Health: Implementation Science at a Glance.[] Accessed 4/5/2021
    1. The Endocrine Society [] Accessed 12/1/2020
    1. Choosing Wisely [] Accessed 12/1/2020
    1. American Thyroid Association [] Accessed 12/1/2020
    1. US preventive service task force [ Accessed 12/1/2020
    1. Davidson KW, Ye S, Mensah GA: Commentary: De-implementation Science: A Virtuous Cycle of Ceasing and Desisting Low-Value Care Before Implementing New High Value Care. Ethn Dis 2017, 27(4):463–468.
    1. McKay VR, Morshed AB, Brownson RC, Proctor EK, Prusaczyk B: Letting Go: Conceptualizing Intervention De-implementation in Public Health and Social Service Settings. Am J Community Psychol 2018, 62(1-2):189–202.
    1. Nilsen P: Making sense of implementation theories, models and frameworks. Implement Sci 2015, 10:53.
    1. Per Nilsen SI, Henna Hasson, Ulrica von Thiele Schwarz and Hanna Augustsson: Theories, models, and frameworks for de-implementation of low-value care: A scoping review of the literature. Implementation Research and Practice 2020, 1:1–15.
    1. Grimshaw JM, Patey AM, Kirkham KR, Hall A, Dowling SK, Rodondi N, Ellen M, Kool T, van Dulmen SA, Kerr EA et al.: De-implementing wisely: developing the evidence base to reduce low-value care. BMJ Qual Saf 2020, 29(5):409–417.
    1. Harris C, Green S, Elshaug AG: Sustainability in Health care by Allocating Resources Effectively (SHARE) 10: operationalising disinvestment in a conceptual framework for resource allocation. BMC Health Serv Res 2017, 17(1):632.
    1. Niven DJ, Mrklas KJ, Holodinsky JK, Straus SE, Hemmelgarn BR, Jeffs LP, Stelfox HT: Towards understanding the de-adoption of low-value clinical practices: a scoping review. BMC Med 2015, 13:255.
    1. Prasad V, Ioannidis JP: Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implement Sci 2014, 9:1.
    1. Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, Moutzouri E, Abdulazeem H, Aertgeerts B, Beecher D, Brito JP et al.: Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ 2019, 365:l2006.
    1. Xu L, Gao J, Wang Q, Yin J, Yu P, Bai B, Pei R, Chen D, Yang G, Wang S et al.: Computer-Aided Diagnosis Systems in Diagnosing Malignant Thyroid Nodules on Ultrasonography: A Systematic Review and Meta-Analysis. Eur Thyroid J 2020, 9(4):186–193.
    1. American Diabetes A: 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2021. Diabetes Care 2021, 44(Suppl 1):S211–S220.
    1. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJ et al.: 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 2017, 27(3):315–389.
    1. Verkerk EW, Tanke MAC, Kool RB, van Dulmen SA, Westert GP: Limit, lean or listen? A typology of low-value care that gives direction in de-implementation. Int J Qual Health Care 2018, 30(9):736–739.
    1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M et al.: 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016, 26(1):1–133.
    1. Norton WE, Chambers DA: Unpacking the complexities of de-implementing inappropriate health interventions. Implement Sci 2020, 15(1).
    1. Kerr EA, Klamerus ML, Markovitz AA, Sussman JB, Bernstein SJ, Caverly TJ, Chou R, Min L, Saini SD, Lohman SE et al.: Identifying Recommendations for Stopping or Scaling Back Unnecessary Routine Services in Primary Care. JAMA Intern Med 2020.
    1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96(7):1911–1930.
    1. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS et al.: Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 2014, 24(12):1670–1751.
    1. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA, Endocrine S: Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96(2):273–288.
    1. Kahwati LC, Weber RP, Pan H, Gourlay M, LeBlanc E, Coker-Schwimmer M, Viswanathan M: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2018, 319(15):1600–1612.
    1. Lin JS, Bowles EJA, Williams SB, Morrison CC: Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2017, 317(18):1888–1903.
    1. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Recommendation Statement. Am Fam Physician 2018, 97(8):Online.
    1. Endocrine Society.Five Things Physicians and Patients Should Question [] Accessed 12/1/2020
    1. Wolf ER, Krist AH, Schroeder AR: Deimplementation in Pediatrics: Past, Present, and Future. JAMA Pediatr 2020.
    1. Wang V, Maciejewski ML, Helfrich CD, Weiner BJ: Working smarter not harder: Coupling implementation to de-implementation. Healthcare 2018, 6(2):104–107.
    1. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA: Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline. J Clin Endocr Metab 2018, 103(5):1715–1744.
    1. Ospina NS, Maraka S, de Ycaza AEE, Brito JP, Castro MR, Morris JC, Montori VM: Prognosis of patients with benign thyroid nodules: a population-based study. Endocrine 2016, 54(1):148–155.
    1. McCoy RG, Lipska KJ, Van Houten HK, Shah ND: Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes. BMJ Open Diabetes Res Care 2020, 8(1).
    1. Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA, Clinical Guidelines Committee of the American College of P: Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Ann Intern Med 2018, 168(8):569–576.
    1. Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, Doubeni CA, Epling JW Jr., Kemper AR, Krist AH et al.: Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2017, 317(18):1882–1887.
    1. Rockwell MS, Wu Y, Salamoun M, Hulver MW, Epling JW: Patterns of Clinical Care Subsequent to Nonindicated Vitamin D Testing in Primary Care. J Am Board Fam Med 2020, 33(4):569–579.
    1. de Vries EF, Struijs JN, Heijink R, Hendrikx RJ, Baan CA: Are low-value care measures up to the task? A systematic review of the literature. BMC Health Serv Res 2016, 16(1):405.
    1. McCoy RG, Van Houten HK, Ross JS, Montori VM, Shah ND: HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: observational population based study. BMJ 2015, 351:h6138.
    1. Colla CH, Mainor AJ, Hargreaves C, Sequist T, Morden N: Interventions Aimed at Reducing Use of Low-Value Health Services: A Systematic Review. Med Care Res Rev 2017, 74(5):507–550.
    1. Powers BW, Jain SH, Shrank WH: De-adopting Low-Value Care: Evidence, Eminence, and Economics. Jama 2020.
    1. Morgan DJ, Leppin AL, Smith CD, Korenstein D: Practical Framework for Understanding and Reducing Medical Overuse: Conceptualizing Overuse Through the Patient-Clinician Interaction. J Hosp Med 2017, 12(5):346–351.
    1. Joseph FG, Rubtsov D, Davoren P: Appropriateness of ultrasound imaging for thyroid pathology, the standard of radiology reporting on thyroid nodules and the detection rates of thyroid malignancy: a tertiary centre retrospective audit. Intern Med J 2020, 50(6):732–740.
    1. Chen DW, Reyes-Gastelum D, Radhakrishnan A, Hamilton AS, Ward KC, Haymart MR: Physician-Reported Misuse of Thyroid Ultrasonography. JAMA Surg 2020, 155(10):984–986.
    1. Hofstede H, van der Burg HAM, Mulder BC, Bohnen AM, Bindels PJE, de Wit NJ, de Schepper EIT, van Vugt SF: Reducing unnecessary vitamin testing in general practice: barriers and facilitators according to general practitioners and patients. BMJ Open 2019, 9(10):e029760.
    1. Sypes EE, de Grood C, Whalen-Browne L, Clement FM, Parsons Leigh J, Niven DJ, Stelfox HT: Engaging patients in de-implementation interventions to reduce low-value clinical care: a systematic review and meta-analysis. BMC Med 2020, 18(1):116.
    1. Prusaczyk B, Swindle T, Curran G: Defining and conceptualizing outcomes for de-implementation: key distinctions from implementation outcomes. Implement Sci Commun 2020, 1:43.
    1. Maratt JK, Kerr EA, Klamerus ML, Lohman SE, Froehlich W, Bhatia RS, Saini SD: Measures Used to Assess the Impact of Interventions to Reduce Low-Value Care: a Systematic Review. J Gen Intern Med 2019, 34(9):1857–1864.
    1. Lohia S, Morris LGT, Roman BR: Association Between Implementation of the 2009 American Thyroid Association Guidelines and De-escalation of Treatment for Low-risk Papillary Thyroid Carcinoma. JAMA Otolaryngol Head Neck Surg 2020.
    1. Henderson J, Bouck Z, Holleman R, Chu C, Klamerus ML, Santiago R, Bhatia RS, Kerr EA: Comparison of Payment Changes and Choosing Wisely Recommendations for Use of Low-Value Laboratory Tests in the United States and Canada. JAMA Intern Med 2020, 180(4):524–531.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit